Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up study

Int J Environ Res Public Health. 2009 Nov;6(11):2822-32. doi: 10.3390/ijerph6112822. Epub 2009 Nov 12.

Abstract

We assess the influence of co-occurring psychiatric disorders on retention in 189 opioid dependent patients in a methadone maintenance treatment (MMT) and determine the incidence of psychiatric co-morbidity during an 18-month follow-up period. About 68.5 % were retained in the MMT. Neither co-occurring mental disorders (chi-square = 0.303, df = 1, p = 0.622) nor methadone doses [85 (88.9) vs. 79.2 (85) mg/day, p = 0.672] were related to retention. In the follow-up period 19 new diagnoses were made, mainly major depression and antisocial and borderline personality disorders. Co-occurring psychiatric disorders should be assessed during MMT follow-up.

Keywords: co-occurring psychiatric disorders; incidence; methadone; retention.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analgesics, Opioid / therapeutic use*
  • Antisocial Personality Disorder / epidemiology
  • Borderline Personality Disorder / epidemiology
  • Confidence Intervals
  • Depressive Disorder, Major / epidemiology
  • Female
  • Humans
  • Incidence
  • Male
  • Mental Disorders / epidemiology*
  • Methadone / therapeutic use*
  • Opioid-Related Disorders / drug therapy*
  • Patient Compliance*
  • Prospective Studies
  • Spain / epidemiology
  • Substance Abuse Treatment Centers*
  • Surveys and Questionnaires
  • Time Factors

Substances

  • Analgesics, Opioid
  • Methadone